LONGENECKER JOHN P PHD 4
4 · Pacira BioSciences, Inc. · Filed Mar 16, 2020
Insider Transaction Report
Form 4
LONGENECKER JOHN P PHD
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-03-12−3,736→ 0 totalExercise: $1.61Exp: 2020-09-02→ Common Stock (3,736 underlying) - Exercise/Conversion
Common Stock
2020-03-12$1.61/sh+3,736$6,015→ 16,497 total
Footnotes (1)
- [F1]The option vested as to 75% of the options on September 2, 2010 and vested as to the remaining 25% of the options in successive equal monthly installments for the subsequent 12 months. The options became exercisable, to the extent vested, from and after the issuer's initial public offering.